Departed
John Coelho
director
PaxMedica, Inc.
In addition, directors Karen J. LaRochelle and John Coelho also resigned from the Board on that date, effective immediately.
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3601–3650 of 35128
In addition, directors Karen J. LaRochelle and John Coelho also resigned from the Board on that date, effective immediately.
On April 1, 2025 (the “Effective Date”), Stephanie Pugliese informed American Eagle Outfitters, Inc. (the “Company”) that she was resigning from the Company’s Board of Directors (the “Board”), as of the Effective Date, due to her upcoming appointment as President and Chief Executive Officer of another publicly traded company.
appointed J. Anthony Gallegos, Jr. to the Board to fill the seat vacated by David Bradshaw
On April 2, 2025, Ms. Christine Pambianchi informed Mobileye Global Inc. (the “Company”) of her resignation from the board of directors (the “Board”), effective April 25, 2025 in connection with her resignation as executive vice president and chief people officer of Intel Corporation, the Company’s controlling shareholder.
Mr. Carrel-Billiard currently serves as the Seller’s Head of Real and Alternative Assets and has been appointed as a Class III director.
Ms. Boyer-Chammard currently serves as the Seller’s Head of Sustainable Transformation and Organization and has been appointed as a Class II director.
The Company announced that Bob Hurst, one of Crestview Partners’ nominees on the Company’s board of directors (the “Board”), retired from the Board effective as of April 1, 2025
On April 3, 2025, the Board of Directors (the “Board”) of Ingersoll Rand Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Michelle Swanenburg as a director of the Board, effective April 3, 2025
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
each of Daniel Scavilla and Keith Pfeil, the directors of Merger Sub immediately prior to the Effective Time, became the directors of Nevro.
each of Daniel Scavilla and Keith Pfeil, the directors of Merger Sub immediately prior to the Effective Time, became the directors of Nevro.
On March 31, 2025, the Board appointed Charles (“Chip”) Victor Bergh to the Board as a Class III director, effective as of April 1, 2025, with an initial term expiring at the Company’s 2025 annual meeting of stockholders.
On March 31, 2025, Beth Pritchard notified e.l.f. Beauty, Inc. (the “ Company ”) of her decision to resign from the Company’s Board of Directors (the “ Board ”) and all committees thereof, effective March 31, 2025.
Robert E. Grove has agreed to resign and has submitted his resignation to the Company’s Board and all committees thereof, effective as of April 2, 2025.
On March 31, 2025, the Board, on the recommendation of the Corporate Governance and Nominating Committee, appointed John A. Fichthorn as a director, effective April 3, 2025
Effective April 2, 2025, Todd W. Arden, a member of the Board, informed the Company of his decision to resign from the Board.
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On March 29, 2025, Chetan Gulati, Leo Gontmakher, and Roman Tkachenko resigned from the Board of Directors of 4Front Ventures Corp.
On March 29, 2025, Chetan Gulati, Leo Gontmakher, and Roman Tkachenko resigned from the Board of Directors of 4Front Ventures Corp.
On March 29, 2025, Chetan Gulati, Leo Gontmakher, and Roman Tkachenko resigned from the Board of Directors of 4Front Ventures Corp.
Effective April 3, 2025, the Board of Directors (the “Board”) of FutureFuel Corp. (the “Company”) increased the size of the Board to nine members and the Company appointed Pamela R. Butcher as a Class C member of the Board until her successor is duly elected and qualified or until her earlier death, resignation or removal.
Effective April 1, 2025, the Company appointed Bant Breen as a Class I member of the Board of Directors of the Company
Effective March 31, 2025, Clark Callandar resigned as a Class I member of the Board of Directors of the Company.
On April 1, 2025, Robert Synowicki, Jr. confirmed to Knight-Swift Transportation Holdings Inc. (the "Company") that he will not be standing for reelection at the Company’s 2025 Annual Meeting of Stockholders.
Thomas J. DeRosa, a member of the board of directors (the “Board”), Chair of the Compensation Committee and a member of the Audit Committee of Empire State Realty Trust, Inc. (the “Company”), notified the Company of his intention to retire and not stand for re-election to the Board at the Company’s 2025 Annual Meeting of Shareholders, currently expected to be held on May 15, 2025 (the “Annual Meeting”).
Effective April 2, 2025, the Board of Directors (the “Board”) of Harmony Biosciences Holdings, Inc. (the “Company”) appointed Ron Philip, age 51, as a Class III director, filling the previously announced vacancy in the Board created by the resignation of Jack Bech Nielsen effective June 27, 2024.
each of Peter Nolan and General C. Robert Kehler notified the Company of their intent not to stand for re-election as a member of the Board at the 2025 Annual Meeting
each of Peter Nolan and General C. Robert Kehler notified the Company of their intent not to stand for re-election as a member of the Board at the 2025 Annual Meeting
appointed Carol DiBattiste, and Thomas D. Mitchell, to serve as independent members of the Board to fill the Board’s current vacancies, effective April 1, 2025
appointed Carol DiBattiste, and Thomas D. Mitchell, to serve as independent members of the Board to fill the Board’s current vacancies, effective April 1, 2025
On March 31, 2025, the board of directors (the “ Board ”) of FIGS, Inc. (the “ Company ”) appointed Jerry Jao to serve as a member of the Board, effective April 1, 2025 (the “ Effective Date ”).
On March 28, 2025, Alexander Baum notified the Board of Directors (the “Board”) of Insight Enterprises, Inc. (the “Company”) that he intends to retire from the Board and will not stand for election at the Company’s next annual meeting of stockholders (the “2025 Annual Meeting”).
it has increased the size of the Company’s Board of Directors (the "Board") to 11 members and has appointed Robert A. DeMichiei to fill the newly created seat on the Board, effective April 2, 2025.
On April 1, 2025, Aurora Cassirer submitted her resignation as a member of the board of directors of NanoVibronix, Inc. (the “Company”), which resignation became effective immediately.
Simultaneously, the Board of Directors of the Company appointed Mr. Thomas Fore to serve as a Director of the Company, effective March 20, 2025.
On April 2, 2025, Esha Randhawa, Charn Deol, and Judy Su each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
On April 2, 2025, Esha Randhawa, Charn Deol, and Judy Su each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
On April 2, 2025, Esha Randhawa, Charn Deol, and Judy Su each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
On April 2, 2025, Esha Randhawa, Charn Deol, Judy Su, and Katharyn Field each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.